Eli Lilly is the world's most valuable drug company, known for its blockbuster anti-obesity drugs that's transforming America. In an episode of "The David Rubenstein Show: Peer to Peer Conversations," CEO Dave Ricks talks about how the company will begin studies this year to see if its weight-loss medicines can also be used to treat addictive behaviors like alcohol abuse, smoking and drug addiction. He also discusses how the company is tackling the issue of counterfeit drugs, as well as the other projects they have on the pipeline. This interview was recorded on December 10 at the Economic Club of Washington DC. See omnystudio.com/listener for privacy information.
From "The David Rubenstein Show"
Listen on your iPhone
Download our iOS app and listen to interviews anywhere. Enjoy all of the listener functions in one slick package. Why not give it a try?
Comments
Add comment Feedback